Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma
NCT00705250
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Hodgkin's Disease
Lymphoma
Interventions
DRUG:
bendamustine hcl
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
[object Object]